Transporter nucleic acids for the intracellular delivery of nucleic acid agents

The invention relates to a method and a pharmaceutical formation for improving the cellular uptake of nucleic acids, particularly nucleic acid agents.

It is based on the novel finding that nucleic acids modified in a particular way improve the cellular uptake of other nucleic acids, particularly double-stranded RNA (siRNA) and consequently act as transporter nucleic acids.

Further Information: PDF

Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937

Contact
Dr. Alexandra Baumgartner

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All news from this category: Technology Offerings

Back to the Homepage

Comments (0)

Write comment

Latest posts

Exploring the evolution of stars

Fabian Schneider leads the new research group “Stellar Evolution Theory” (SET) at the Heidelberg Institute for Theoretical Studies (HITS). The astrophysicist explores the turbulent life of massive binary stars and…

Sustainable insulating material for shipping temperature-sensitive products

Researchers at the Institute of Natural Products Engineering at TU Dresden have developed an insulating material made from recycled paper for shipping temperature-sensitive foods and medicines. As part of a…

Helium nuclei at the surface of heavy nuclei discovered

Research team confirms a new nuclear property predicted by theory Scientists are able to selectively knockout nucleons and preformed nuclear clusters from atomic nuclei using high-energy proton beams. In an…

Partners & Sponsors

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close